e-learning
resources
Paris 2018
Sunday, 16.09.2018
Thoracic surgery, pleural effusions and other general thoracic surgery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Synchronous primary lung cancers;a clinical challenge in modern thoracic oncology
G. Hardavella (London, United Kingdom), I. Karampinis (Athens, Greece), A. Mpairaktari (Athens, Greece), G. Aravantinos (Athens, Greece), N. Anastasiou (Athens, Greece)
Source:
International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery
Session:
Thoracic surgery, pleural effusions and other general thoracic surgery
Session type:
Poster Discussion
Number:
1743
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Hardavella (London, United Kingdom), I. Karampinis (Athens, Greece), A. Mpairaktari (Athens, Greece), G. Aravantinos (Athens, Greece), N. Anastasiou (Athens, Greece). Synchronous primary lung cancers;a clinical challenge in modern thoracic oncology. 1743
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Lung cancer classification and characterisation in daily practice of thoracic oncology
Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science
Year: 2014
Implications of new lung adenocarcinoma classification for oncologists
Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update
Year: 2009
The clinical benefit of personalised medicine in lung cancer
Source: International Congress 2014 – Understanding the benefit of current personalised medicine platforms
Year: 2014
Milestones in the management of lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Improving tumour documentation in thoracic oncology: what can we learn from each other?
Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe
Year: 2012
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the thoracic surgeon
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017
Possibility of noninvasive differential diagnostics of lung tuberculosis and lung cancer in oncologic hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003
No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team
Source: Eur Respir J 2009; 33: 941-942
Year: 2009
Immunotherapy: a new standard of care in thoracic malignancies?
Source: Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017
Year: 2018
The use of surgical services in the management of suspected lung cancers
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012
Management of airway involvement in patients with advanced esophageal cancer
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Integration of interventional bronchoscopy in the management of lung cancer
Source: Eur Respir Rev 2015; 24: 378-391
Year: 2015
Do thoracic surgeons outperform general surgeons in lung cancer surgery? A single centre study
Source: Eur Respir J 2001; 18: Suppl. 33, 374s
Year: 2001
Slow-growing lung cancer as an emerging entity: from screening to clinical management
Source: Eur Respir J 2013; 42: 1706-1722
Year: 2013
Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Practical tools for implementing early palliative care in advanced lung cancer
Source: Eur Respir J 2016; 47: 1010-1012
Year: 2016
Clinical presentations of recurrent lung cancer after surgery
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007
Impact of the COVID19 pandemic on patterns of respiratory, thoracic oncology and thoracic surgery outpatient care
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Single-institution experience of surgical management of metastasises of colorectal cancer in lungs: Lessons learned
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept